Analyst firms · H.C. Wainwright · COLL

H.C. Wainwright COLL price target and rating history

Collegium Pharmaceutical Inc. (COLL) · Health Care

H.C. Wainwright rates Collegium Pharmaceutical Inc. (COLL) Buy with a $47 price target, as of its latest action on Jul 30, 2024. It has published 4 rating actions on COLL since August 2021, including 1 upgrade and 1 downgrade. Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.

Current rating
Buy
Price target
$47
Median target, all firms
$49.50
Actions on COLL
4

H.C. Wainwright price target on COLL

$47$38$2820222023202420252026
H.C. Wainwright price target on COLL, each point a stated target, August 2021 to July 2024.

Every H.C. Wainwright rating on COLL

How other firms rate COLL

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
OppenheimerOutperform$50Sep 23, 2026
Truist SecuritiesBuy$49Sep 9, 2026
Leerink PartnersOutperform$45Sep 9, 2026
BarclaysOverweight$58Dec 9, 2025

Questions about H.C. Wainwright and COLL

What is H.C. Wainwright's price target for COLL?
H.C. Wainwright's latest stated price target for Collegium Pharmaceutical Inc. (COLL) is $47, from its action on Jul 30, 2024.
What is H.C. Wainwright's rating on COLL?
H.C. Wainwright rates COLL Buy, a bullish rating, as of Jul 30, 2024.
When did H.C. Wainwright last change its view on COLL?
On Jul 30, 2024, H.C. Wainwright upgrades to Buy from Neutral, price target $47.
How does H.C. Wainwright's COLL target compare with other analysts?
Across 4 firms with a COLL price target in the last 12 months, the median target is $49.50.

More COLL rating histories

All H.C. Wainwright ratingsCOLL news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.